135 related articles for article (PubMed ID: 36648137)
1. Refining patients' care in myelofibrosis: looking at second primary malignancies.
Polverelli N; Malagola M; Russo D
Leuk Lymphoma; 2022 Dec; 63(14):3274-3275. PubMed ID: 36648137
[No Abstract] [Full Text] [Related]
2. Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients.
Mora B; Rumi E; Guglielmelli P; Barraco D; Maffioli M; Rambaldi A; Caramella M; Komrokji R; Gotlib J; Kiladjian JJ; Cervantes F; Devos T; Palandri F; De Stefano V; Ruggeri M; Silver RT; Benevolo G; Albano F; Cavalloni C; Pietra D; Barbui T; Rotunno G; Cazzola M; Vannucchi AM; Giorgino T; Passamonti F
Cancer Med; 2019 Aug; 8(9):4089-4092. PubMed ID: 31173472
[TBL] [Abstract][Full Text] [Related]
3. Development of extramedullary sites of leukaemia during ruxolitinib therapy for myelofibrosis.
Kremyanskaya M; Mascarenhas J; Rampal R; Hoffman R
Br J Haematol; 2014 Oct; 167(1):144-6. PubMed ID: 24862179
[No Abstract] [Full Text] [Related]
4. Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients.
Maffioli M; Giorgino T; Mora B; Iurlo A; Elli E; Finazzi MC; Caramella M; Rumi E; Carraro MC; Polverelli N; D'Adda M; Malato S; Rossi M; Molteni A; Vismara A; Sissa C; Spina F; Anghilieri M; Cattaneo D; Renso R; Bellini M; Pioltelli ML; Cavalloni C; Barraco D; Accetta R; Bertù L; Della Porta MG; Passamonti F
Blood Adv; 2019 Nov; 3(21):3196-3200. PubMed ID: 31698448
[TBL] [Abstract][Full Text] [Related]
5. Association between myelofibrosis and risk of non-hematologic malignancies: a population-based retrospective cohort study.
Saliba W; Khudyakova M; Mishchenko E; Cohen S; Rennert G; Preis M
Ann Hematol; 2020 May; 99(5):1007-1016. PubMed ID: 32157418
[TBL] [Abstract][Full Text] [Related]
6. Risk of mortality and second malignancies in primary myelofibrosis before and after ruxolitinib approval.
Thomas JW; Jamy O; Shah MV; Vachhani P; Go RS; Goyal G
Leuk Res; 2022 Jan; 112():106770. PubMed ID: 34920340
[TBL] [Abstract][Full Text] [Related]
7. Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database study.
Joshi U; Bhattarai A; Gaire S; Gill S; Agrawal V; Yadav SK; Low SK; Dhakal P; Bhatt VR; Kouides PA
Leuk Lymphoma; 2022 Dec; 63(14):3456-3461. PubMed ID: 36120968
[TBL] [Abstract][Full Text] [Related]
8. Acute non-lymphocytic leukaemia and myelofibrosis following sequential hemibody irradiation for prostatic carcinoma.
Graham P
Clin Oncol (R Coll Radiol); 1992 May; 4(3):203. PubMed ID: 1586642
[No Abstract] [Full Text] [Related]
9. Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
Polverelli N; Elli EM; Abruzzese E; Palumbo GA; Benevolo G; Tiribelli M; Bonifacio M; Tieghi A; Caocci G; D'Adda M; Bergamaschi M; Binotto G; Heidel FH; Cavazzini F; Crugnola M; Pugliese N; Bosi C; Isidori A; Bartoletti D; Auteri G; Latagliata R; Gandolfi L; Martino B; Scaffidi L; Cattaneo D; D'Amore F; Trawinska MM; Stella R; Markovic U; Catani L; Pane F; Cuneo A; Krampera M; Semenzato G; Lemoli RM; Vianelli N; Breccia M; Russo D; Cavo M; Iurlo A; Palandri F
Br J Haematol; 2021 Apr; 193(2):356-368. PubMed ID: 33222197
[TBL] [Abstract][Full Text] [Related]
10. Dengue fever and bone marrow myelofibrosis.
Qing X; Sun N; Yeh J; Yue C; Cai J
Exp Mol Pathol; 2014 Oct; 97(2):208-10. PubMed ID: 25016180
[TBL] [Abstract][Full Text] [Related]
11. Intracranial sclerosing extramedullary haematopoietic tumour mimicking meningioma in a patient with myelofibrosis: Case report.
Woodward Z; Robertson T; Sim S; Tollesson G
J Clin Neurosci; 2021 Jun; 88():268-270. PubMed ID: 33992195
[TBL] [Abstract][Full Text] [Related]
12. The association of carcinoid tumors of the rectum with myelofibrosis: report of two cases.
Nelson RL
Dis Colon Rectum; 1981 Oct; 24(7):548-9. PubMed ID: 7297366
[TBL] [Abstract][Full Text] [Related]
13. Osteolytic bone lesions in patients with primary myelofibrosis: A systematic review.
Battukh N; Ali E; Yassin M
Acta Biomed; 2022 Jan; 92(6):e2021478. PubMed ID: 35075062
[TBL] [Abstract][Full Text] [Related]
14. [Hematologic Malignancies/Pediatric Malignancies. I. Ruxolitinib Therapy for Myelofibrosis and Polycythemia Vera].
Komatsu N
Gan To Kagaku Ryoho; 2016 May; 43(5):530-4. PubMed ID: 27344680
[No Abstract] [Full Text] [Related]
15. Myelofibrosis in neuroblastoma.
Labotka RJ; Morgan ER
Med Pediatr Oncol; 1982; 10(1):21-6. PubMed ID: 7062895
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing autoimmune myelofibrosis from primary myelofibrosis.
Marcellino B; El Jamal SM; Mascarenhas JO
Clin Adv Hematol Oncol; 2018 Sep; 16(9):619-626. PubMed ID: 30256778
[TBL] [Abstract][Full Text] [Related]
17. Myelofibrosis with myeloid metaplasia in a patient with relapsed Hodgkin's lymphoma who underwent autologous hematopoietic stem cell transplantation.
Massa FS; Rolón JM; Pavlovsky S
Hematology; 2007 Dec; 12(6):487-8. PubMed ID: 17852452
[TBL] [Abstract][Full Text] [Related]
18. Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases.
Angotzi F; Visentin A; Scarmozzino F; Cellini A; Bertorelle R; Pizzi M; Binotto G; Dei Tos AP; Trentin L
Curr Oncol; 2022 Feb; 29(3):1455-1460. PubMed ID: 35323322
[TBL] [Abstract][Full Text] [Related]
19. [18F-FDG-PET/CT is effective in distinguishing myelofibrosis due to bone marrow infiltration of diffuse large B-cell lymphoma from triple-negative primary myelofibrosis].
Kumagai T; Satoh Y; Koshiishi M; Ooishi S; Sueki Y; Nakajima K; Mitsumori T; Kirito K
Rinsho Ketsueki; 2017; 58(3):228-232. PubMed ID: 28381690
[TBL] [Abstract][Full Text] [Related]
20. Myelofibrosis and benzene exposure.
Tondel M; Persson B; Carstensen J
Occup Med (Lond); 1995 Feb; 45(1):51-2. PubMed ID: 7703476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
